Home » Topics » Regulatory

Regulatory
RSS

New indication for Arava recommended for approval

March 10, 2003

Lercanidipine 20 mg approved in Europe

March 7, 2003

Oral tazarotene completes phase III studies

March 7, 2003

Myoview approved for assessment of left ventricular function

March 6, 2003

Priority review granted for Arixtra sNDA

March 6, 2003

Avelox approved for CAP pneumonia due to penicillin-resistant S. pneumoniae

March 6, 2003

Positive opinion in E.U. for long-term use of Zometa

March 5, 2003

Avandia label broadened in the U.S.

March 4, 2003

FDA approves Oxytrol for overactive bladder

March 3, 2003

Risperdal Consta approved in Spain

Feb. 28, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.